Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Hydration Status and Kidney Health of Factory Workers Exposed to Heat Stress: A Pilot Feasibility Study.

Nerbass FB, Moist L, Clark WF, Vieira MA, Pecoits-Filho R.

Ann Nutr Metab. 2019;74 Suppl 3:30-37. doi: 10.1159/000500373. Epub 2019 Jun 14.

2.

Is high fluid intake good for the kidney?

Clark WF.

Kidney Res Clin Pract. 2019 Jun 30;38(2):135-137. doi: 10.23876/j.krcp.19.043. No abstract available.

3.

Introduction to therapeutic plasma exchange.

Clark WF, Huang SS.

Transfus Apher Sci. 2019 Jun;58(3):228-229. doi: 10.1016/j.transci.2019.04.004. Epub 2019 Apr 26. Review.

PMID:
31047822
4.

A matched case-control study to assess the association between non-steroidal anti-inflammatory drug use and thrombotic microangiopathy.

Liu AR, Hildebrand AM, Dixon S, Sontrop JM, Clark WF, Lazo-Langner A, Nash D, Garg AX.

PLoS One. 2018 Aug 24;13(8):e0202801. doi: 10.1371/journal.pone.0202801. eCollection 2018.

5.

Effect of Coaching to Increase Water Intake on Kidney Function Decline in Adults With Chronic Kidney Disease: The CKD WIT Randomized Clinical Trial.

Clark WF, Sontrop JM, Huang SH, Gallo K, Moist L, House AA, Cuerden MS, Weir MA, Bagga A, Brimble S, Burke A, Muirhead N, Pandeya S, Garg AX.

JAMA. 2018 May 8;319(18):1870-1879. doi: 10.1001/jama.2018.4930.

6.

Occupational Heat Stress and Kidney Health: From Farms to Factories.

Nerbass FB, Pecoits-Filho R, Clark WF, Sontrop JM, McIntyre CW, Moist L.

Kidney Int Rep. 2017 Aug 31;2(6):998-1008. doi: 10.1016/j.ekir.2017.08.012. eCollection 2017 Nov. Review.

7.

The vasopressin system: new insights for patients with kidney diseases: Epidemiological evidence and therapeutic perspectives.

Clark WF, Devuyst O, Roussel R.

J Intern Med. 2017 Oct;282(4):310-321. doi: 10.1111/joim.12654. Epub 2017 Sep 14. Review.

PMID:
28905441
8.

The Chronic Kidney Disease Water Intake Trial: Protocol of a Randomized Controlled Trial.

Clark WF, Huang SH, Garg AX, Gallo K, House AA, Moist L, Weir MA, Sontrop JM.

Can J Kidney Health Dis. 2017 Aug 22;4:2054358117725106. doi: 10.1177/2054358117725106. eCollection 2017.

9.
10.

Simple diagnosis and treatment algorithm for adult thrombotic microangiopathy.

Clark WF, Patriquin C, Licht C, Huang SH, Rock G.

Transfus Apher Sci. 2017 Feb;56(1):50-51. doi: 10.1016/j.transci.2016.12.018. Epub 2016 Dec 31. Review. No abstract available.

PMID:
28139433
11.

Plasmapheresis for the treatment of kidney diseases.

Clark WF, Huang SS, Walsh MW, Farah M, Hildebrand AM, Sontrop JM.

Kidney Int. 2016 Nov;90(5):974-984. doi: 10.1016/j.kint.2016.06.009. Epub 2016 Aug 3. Review.

PMID:
27498206
12.

How we treat thrombotic thrombocytopenic purpura: Results of a Canadian TTP practice survey.

Patriquin CJ, Clark WF, Pavenski K, Arnold DM, Rock G, Foley SR; Canadian Apheresis Group.

J Clin Apher. 2017 Aug;32(4):246-256. doi: 10.1002/jca.21489. Epub 2016 Jul 31.

PMID:
27476033
13.

The role of plasma exchange in treating post-transplant focal segmental glomerulosclerosis: A systematic review and meta-analysis of 77 case-reports and case-series.

Kashgary A, Sontrop JM, Li L, Al-Jaishi AA, Habibullah ZN, Alsolaimani R, Clark WF.

BMC Nephrol. 2016 Jul 29;17(1):104. doi: 10.1186/s12882-016-0322-7. Review.

14.

International Society of Nephrology-Hydration and Kidney Health Initiative - Expanding Research and Knowledge.

Moist LM, Clark WF, Segantini L, Damster S, Le Bellego L, Wong G, Tonelli M.

Ann Nutr Metab. 2016;68 Suppl 2:32-4. doi: 10.1159/000446222. Epub 2016 Jun 16.

15.

Treatment of severe, refractory and rapidly evolving thrombotic thrombocytopenic purpura.

Acedillo RR, Govind M, Kashgary A, Clark WF.

BMJ Case Rep. 2016 Jun 9;2016. pii: bcr2016215491. doi: 10.1136/bcr-2016-215491.

16.

Hydration and Chronic Kidney Disease Progression: A Critical Review of the Evidence.

Clark WF, Sontrop JM, Huang SH, Moist L, Bouby N, Bankir L.

Am J Nephrol. 2016;43(4):281-92. doi: 10.1159/000445959. Epub 2016 May 3. Review.

17.

Long-term outcomes of thrombotic microangiopathy treated with plasma exchange: A systematic review.

Thejeel B, Garg AX, Clark WF, Liu AR, Iansavichus AV, Hildebrand AM.

Am J Hematol. 2016 Jun;91(6):623-30. doi: 10.1002/ajh.24339. Epub 2016 Apr 6. Review.

18.

Consecutive first-morning urine samples to measure change in the albumin-to-creatinine ratio: a pilot study of a home urine collection protocol.

Sontrop JM, Garg AX, Li L, Gallo K, Schumann V, Winick-Ng J, Clark WF, Weir MA.

Can J Kidney Health Dis. 2016 Feb 1;3:3. doi: 10.1186/s40697-016-0095-8. eCollection 2016.

19.

Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial.

Sontrop JM, Huang SH, Garg AX, Moist L, House AA, Gallo K, Clark WF.

BMJ Open. 2015 Nov 24;5(11):e008634. doi: 10.1136/bmjopen-2015-008634.

20.

Primary and Secondary Thrombotic Microangiopathy Referred to a Single Plasma Exchange Center for Suspected Thrombotic Thrombocytopenic Purpura: 2000-2011.

Dahlan R, Sontrop JM, Li L, Ghadieh O, Clark WF.

Am J Nephrol. 2015;41(6):429-37. doi: 10.1159/000437001. Epub 2015 Jul 14.

PMID:
26183258
21.

Increasing Water Intake in Chronic Kidney Disease: Why? Safe? Possible?

Clark WF, Sontrop JM, Moist L, Huang SH.

Ann Nutr Metab. 2015;66 Suppl 3:18-21. doi: 10.1159/000381241. Epub 2015 Jun 18.

22.

Characteristics and Outcomes of AKI Treated with Dialysis during Pregnancy and the Postpartum Period.

Hildebrand AM, Liu K, Shariff SZ, Ray JG, Sontrop JM, Clark WF, Hladunewich MA, Garg AX.

J Am Soc Nephrol. 2015 Dec;26(12):3085-91. doi: 10.1681/ASN.2014100954. Epub 2015 May 14.

23.

Maternal, pregnancy and fetal outcomes in de novo anti-glomerular basement membrane antibody disease in pregnancy: a systematic review.

Thomson B, Joseph G, Clark WF, Hladunewich M, Patel A, Blake P, Eastabrook G, Matsui D, Sharma A, House A.

Clin Kidney J. 2014 Oct;7(5):450-6. doi: 10.1093/ckj/sfu086. Epub 2014 Aug 14.

24.

A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab.

Clark WF, Rock G, Barth D, Arnold DM, Webert KE, Yenson PR, Kelton JG, Li L, Foley SR; members of Canadian Apheresis Group.

Br J Haematol. 2015 Jul;170(2):208-17. doi: 10.1111/bjh.13408. Epub 2015 Apr 8.

PMID:
25855259
25.

Patients' quality of life after stopping plasma exchange: a pilot study.

Dahlan R, McCormick BB, Alkhattabi M, Gallo K, Clark WF, Rock G.

Transfus Apher Sci. 2014 Oct;51(2):137-40. doi: 10.1016/j.transci.2014.04.012. Epub 2014 May 15.

PMID:
24877902
26.

Hydration and kidney health.

Bouby N, Clark WF, Roussel R, Taveau C, Wang CJ.

Obes Facts. 2014;7 Suppl 2:19-32. doi: 10.1159/000360889. Epub 2014 Apr 4. No abstract available.

27.

"Drink at least 8 glasses of water a day to be healthy???".

Clark WF, Susan Huang SH, Garg AX, House A, Moist LM, Weir M, Sontrop JM.

Home Healthc Nurse. 2014 Apr;32(4):237-42. doi: 10.1097/NHH.0000000000000050.

PMID:
24685756
28.

Plasma exchange for kidney disease: what is the best evidence?

Hildebrand AM, Huang SH, Clark WF.

Adv Chronic Kidney Dis. 2014 Mar;21(2):217-27. doi: 10.1053/j.ackd.2014.01.008. Review.

PMID:
24602471
29.

Hyponatremia and sodium picosulfate bowel preparations in older adults.

Weir MA, Fleet JL, Vinden C, Shariff SZ, Liu K, Song H, Jain AK, Gandhi S, Clark WF, Garg AX.

Am J Gastroenterol. 2014 May;109(5):686-94. doi: 10.1038/ajg.2014.20. Epub 2014 Mar 4.

PMID:
24589671
30.

Canadian Society of Nephrology 2014 clinical practice guideline for timing the initiation of chronic dialysis.

Nesrallah GE, Mustafa RA, Clark WF, Bass A, Barnieh L, Hemmelgarn BR, Klarenbach S, Quinn RR, Hiremath S, Ravani P, Sood MM, Moist LM; Canadian Society of Nephrology.

CMAJ. 2014 Feb 4;186(2):112-7. doi: 10.1503/cmaj.130363. No abstract available.

31.

Verotoxigenic Escherichia coli: costs of illness in Canada, including long-term health outcomes.

Sockett P, Goebel SE, Varela NP, Guthrie A, Wilson J, Guilbault LA, Clark WF.

J Food Prot. 2014 Feb;77(2):216-26. doi: 10.4315/0362-028X.JFP-13-177.

PMID:
24490915
32.

The Canadian Society of Nephrology methods in developing and adapting clinical practice guidelines: a review.

Mustafa RA, Levin A, Akbari A, Foster BJ, Zimmerman D, Nesrallah GE, Knoll GA, Rioux JP, Barton J, Ruzicka M, Muirhead N, Moist L, Pannu N, McFarlane P, Klarenbach S, Samuel S, Clark WF, Hemmelgarn BR.

Can J Kidney Health Dis. 2014 May 12;1:5. doi: 10.1186/2054-3581-1-5. eCollection 2014. Review.

33.

The chronic kidney disease Water Intake Trial (WIT): results from the pilot randomised controlled trial.

Clark WF, Sontrop JM, Huang SH, Gallo K, Moist L, House AA, Weir MA, Garg AX.

BMJ Open. 2013 Dec 20;3(12):e003666. doi: 10.1136/bmjopen-2013-003666.

34.

Timing of peritoneal dialysis initiation and mortality: analysis of the Canadian Organ Replacement Registry.

Jain AK, Sontrop JM, Perl J, Blake PG, Clark WF, Moist LM.

Am J Kidney Dis. 2014 May;63(5):798-805. doi: 10.1053/j.ajkd.2013.10.054. Epub 2013 Dec 12.

PMID:
24332765
35.

Choice of GFR estimating equation influences dialysis initiation and mortality.

Wilson B, Sontrop JM, Clark WF.

Nephrol Nurs J. 2013 Jul-Aug;40(4):339-46; quiz 347.

PMID:
24175444
36.

Dialysis initiation: what's the rush?

Rosansky SJ, Cancarini G, Clark WF, Eggers P, Germaine M, Glassock R, Goldfarb DS, Harris D, Hwang SJ, Imperial EB, Johansen KL, Kalantar-Zadeh K, Moist LM, Rayner B, Steiner R, Zuo L.

Semin Dial. 2013 Nov-Dec;26(6):650-7. doi: 10.1111/sdi.12134. Epub 2013 Sep 19. Review.

PMID:
24066675
37.

Tandem hemodialysis and plasma exchange.

Filler G, Clark WF, Huang SH.

Pediatr Nephrol. 2014 Nov;29(11):2077-82. doi: 10.1007/s00467-013-2620-7. Epub 2013 Sep 11. Review.

PMID:
24022368
38.

Has the yearly increase in the renal replacement therapy population ended?

Rosansky SJ, Clark WF.

J Am Soc Nephrol. 2013 Sep;24(9):1367-70. doi: 10.1681/ASN.2013050458. Epub 2013 Jul 18.

39.

Hypertension in pregnancy after Escherichia coli O157:H7 gastroenteritis: a cohort study.

Nevis IF, Sontrop JM, Clark WF, Huang A, McDonald S, Thabane L, Moist L, Macnab JJ, Suri R, Garg AX.

Hypertens Pregnancy. 2013 Nov;32(4):390-400. doi: 10.3109/10641955.2013.810238. Epub 2013 Jul 11.

PMID:
23844780
40.

Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data.

Sontrop JM, Dixon SN, Garg AX, Buendia-Jimenez I, Dohein O, Huang SH, Clark WF.

Am J Nephrol. 2013;37(5):434-42. doi: 10.1159/000350377. Epub 2013 Apr 17.

41.

Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR).

Bennett CL, Jacob S, Dunn BL, Georgantopoulos P, Zheng XL, Kwaan HC, McKoy JM, Magwood JS, Qureshi ZP, Bandarenko N, Winters JL, Raife TJ, Carey PM, Sarode R, Kiss JE, Danielson C, Ortel TL, Clark WF, Ablin RJ, Rock G, Matsumoto M, Fujimura Y.

Br J Haematol. 2013 Jun;161(6):896-8. doi: 10.1111/bjh.12303. Epub 2013 Mar 27. No abstract available.

42.

Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial.

Walsh M, Merkel PA, Peh CA, Szpirt W, Guillevin L, Pusey CD, De Zoysa J, Ives N, Clark WF, Quillen K, Winters JL, Wheatley K, Jayne D; PEXIVAS Investigators.

Trials. 2013 Mar 14;14:73. doi: 10.1186/1745-6215-14-73.

43.

ADAMTS-13 may not predict disease or outcome in patients with Thrombotic Thrombocytopenic Purpura.

Rock G, Clark WF, Anderson D, Benny B, Sutton D, Leblond P, Sternbach M, Sontrop J; Members of the Canadian Apheresis Group.

Thromb Res. 2013 Apr;131(4):308-12. doi: 10.1016/j.thromres.2013.01.024. Epub 2013 Feb 11.

PMID:
23411128
44.

Cardiovascular disease after Escherichia coli O157:H7 gastroenteritis.

Hizo-Abes P, Clark WF, Sontrop JM, Young A, Huang A, Thiessen-Philbrook H, Austin PC, Garg AX; Walkerton Health Study Investigators.

CMAJ. 2013 Jan 8;185(1):E70-7. doi: 10.1503/cmaj.112161. Epub 2012 Nov 19.

45.

Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR).

Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, Raife TJ, Carey PM, Sarode R, Kiss JE, Danielson C, Ortel TL, Clark WF, Rock G, Matsumoto M, Fujimura Y, Zheng XL, Chen H, Chen F, Armstrong JM, Raisch DW, Bennett CL.

Semin Thromb Hemost. 2012 Nov;38(8):845-53. doi: 10.1055/s-0032-1328894. Epub 2012 Oct 30. Review.

46.

Early dialysis initiation and rates and timing of withdrawal from dialysis in Canada.

Ellwood AD, Jassal SV, Suri RS, Clark WF, Na Y, Moist LM.

Clin J Am Soc Nephrol. 2013 Feb;8(2):265-70. doi: 10.2215/CJN.01000112. Epub 2012 Oct 18.

47.

Ustekinumab associated thrombotic thrombocytopenic purpura.

Huang SH, Xenocostas A, Moist LM, Crowther M, Moore JC, Clark WF.

Transfus Apher Sci. 2012 Oct;47(2):185-8. doi: 10.1016/j.transci.2012.06.024. Epub 2012 Aug 1.

PMID:
22858359
48.

The road to hell is paved with good intentions.

Clark WF.

Semin Dial. 2012 Sep-Oct;25(5):520-1. doi: 10.1111/j.1525-139X.2012.01116.x. Epub 2012 Jul 24. No abstract available.

PMID:
22823177
49.

Glomerular disease search filters for Pubmed, Ovid Medline, and Embase: a development and validation study.

Hildebrand AM, Iansavichus AV, Lee CW, Haynes RB, Wilczynski NL, McKibbon KA, Hladunewich MA, Clark WF, Cattran DC, Garg AX.

BMC Med Inform Decis Mak. 2012 Jun 6;12:49. doi: 10.1186/1472-6947-12-49.

50.

Plasma exchange for renal disease: evidence and use 2011.

Clark WF.

J Clin Apher. 2012;27(3):112-6. doi: 10.1002/jca.21221. Epub 2012 Apr 25. Review.

PMID:
22535650

Supplemental Content

Loading ...
Support Center